⚡ZurzAI.com⚡

Behold.ai, a UK-based medical technology company, offers AI-powered radiology diagnostic tools that aim to address healthcare challenges globally. Their flagship technology, red dot®, is an AI-enabled CT and X-Ray medical diagnosis platform. The platform features two core products: the red dot® Lung Cancer Detection Platform and red dot® CTH V1.

Red dot® Solutions:

• Lung Cancer Detection Platform: This AI-enabled system aids in fast-tracking lung cancer diagnosis by almost instantly identifying and triaging suspected cases, thereby reducing patient CT wait times from weeks to minutes. It allows for increased radiology capacity by autonomously reporting high confidence normal scans, reducing reliance on outsourcing, and potentially cutting costs by up to 70%.

• CTH V1 Platform: This platform is designed to triage acute findings in CT Head examinations. It identifies intracranial hemorrhage (ICH) or acute infarcts within 5 minutes, facilitating quicker treatment processes and reducing radiology workloads.

Case Studies:

Behold.ai's services have demonstrated significant impact in various NHS Trust hospitals:

• Calderdale and Huddersfield NHS Trust: The introduction of red dot® at this Trust resulted in a 71% reduction in wait times for suspected lung cancer cases and reported over 25% of the CXR workload within seconds.

• Somerset NHS Foundation Trust: The trial of the red dot® service reduced the lung cancer pathway from 7 to 3 days, providing a 57% reduction in wait times for patients.

• Mid and South Essex NHS Trust: This hospital leveraged red dot® to address a backlog of CXR cases, significantly reducing the reporting time from weeks to days.

Regulatory and Recognition Highlights:

• Behold.ai is distinguished as the sole AI supplier regulated by the UK's Care Quality Commission.
• The company has also received FDA 510(k) clearance for triaging pneumothorax cases and holds the CE Mark for diagnostic applications, underlining its technological legitimacy and worldwide applicability.

Global Outreach and Partnerships:

• In India, Behold.ai partnered with Apollo Hospitals, enhancing COVID-19 diagnosis through rapid CXR exam triaging.
• In the US, Behold.ai's partnership with Merative aids in ensuring swift triage notifications.
• The company actively participated in the AWS Diagnostic Development Initiative to address COVID-19 diagnostics, reflecting its adaptability to global healthcare needs.

Achievements and Awards:

Behold.ai has been recognized for its contribution to medical technology innovation, notably winning awards for its digital health solutions.

Team and Leadership:

• The leadership at Behold.ai includes Simon Rasalingham as the CEO and Dr. Tom Naunton-Morgan as the Chief Medical Officer, supported by a team with extensive experience in radiology and healthcare technology.

In summary, Behold.ai’s red dot® technology provides a substantial contribution toward enhancing diagnostic accuracy, reducing patient wait times, and improving healthcare outcomes through its AI-enabled solutions across both the UK and international landscapes. Their approach integrates seamlessly with existing healthcare workflows to support clinicians and improve overall efficiency in radiological diagnostics.